Avian Reovirus

Overview and Taxonomy of Avian Reovirus

Avian reoviruses (ARVs) are non-enveloped double-stranded RNA viruses classified within the genus Orthoreovirus in the family Reoviridae [7]. These viruses exhibit a segmented genome architecture that is central to their genetic diversity and capacity for reassortment among various viral strains. The segmented genome comprises 10 double-stranded RNA segments, with particular focus on the S1 segment encoding the σC protein – a major antigenic determinant used widely for genotyping and phylogenetic studies [3, 7]. The σC gene’s hypervariability, along with observed nucleotide insertions and deletions in field variants, provides critical molecular markers that differentiate among distinct genotypic clusters [4, 6, 9].

Taxonomically, ARVs have been subdivided into multiple genotypic clusters (sometimes numbered from I to VII) based on the amino acid sequences of the σC protein and other genomic segments [1, 5, 9]. For instance, the emergence of strains within clusters II, III, IV, and V has been documented in diverse geographic regions, with some clusters showing remarkable divergence from the vaccine strains that are historically used for prophylaxis [4, 9]. In some regions, such as China, epidemiological studies have revealed the circulation of ARV variants that fall into genotype VI, characterized by significant differences in the σC coding region relative to historic isolates like the S1133 strain [4]. This genotypic heterogeneity underscores the virus’s rapid evolutionary dynamics that require constant monitoring and updated control measures.

The morphology of ARVs further supports their taxonomic classification. Electron microscopy frequently reveals icosahedral capsids with a distinctive double-layered architecture. The outer capsid proteins, including σB and σC, not only determine the serological identity of the virus but also mediate host cell attachment and entry – a process that is tightly linked to cell-surface receptors and membrane microdomains such as cholesterol-rich lipid rafts [10, 14]. The interplay between the virus capsid proteins and host cell structures, including annexin A2 and adhesion G protein-coupled receptor latrophilin-2, initiate signaling cascades such as those involving Src and p38 MAPK, which in turn facilitate caveolae-mediated viral endocytosis [10]. This cellular receptor-binding and entry process is both a defining characteristic and a functional basis for delineating ARV strains in relation to their host range and pathogenicity.

Genotypic classification of ARVs, often based on σC gene sequences, has revealed extensive variability. Comprehensive molecular analyses have demonstrated that nucleotide and amino acid identities between field isolates and vaccine strains can differ by as much as 40%–50%, with distinct genotypes dominating in certain countries [9, 12]. The evolution of ARV strains frequently reflects not only the intensified poultry production systems but also the selective pressures imposed by vaccination and biosecurity practices [8]. For example, phylogenetic reconstructions based on thousands of σC sequences suggest that ARV originated several centuries ago, and its modern diversification aligns with intensification in poultry farming practices and international trade patterns [8].

Furthermore, reassortment events between the ten RNA segments constitute an additional layer of complexity in ARV taxonomy. Segment-based temporal analyses have illustrated that while some segments (e.g., those encoding outer capsid proteins) exhibit high variability, others involved in viral replication and core formation remain relatively conserved [5, 11]. This mosaicism plays a critical role in ARV adaptation and cross-species transmission, wherein spillover events between chickens, turkeys, and wild birds are observed [2, 8]. The frequent emergence of variant strains, some of which display reduced cross-neutralization with vaccine-induced antibodies, underscores the challenge in constructing an effective, broad-spectrum vaccine strategy [4, 9, 12].

Notably, the biologic and antigenic diversity of ARVs is not merely of academic interest. These viruses have a profound economic impact on global poultry production, with outbreaks causing viral arthritis, tenosynovitis, and growth retardation among broilers and layers [7]. Comprehensive surveillance data from diverse geographical regions – including Brazil, the United States, China, and Israel – have demonstrated that many clinical cases of arthritis and malabsorption are associated with ARV infections that display significant genetic divergence from conventional vaccine strains [1, 9, 13]. The dynamic nature of ARV taxonomy, therefore, necessitates regular monitoring by organizations such as the World Organisation for Animal Health (WOAH) and international authorities like the FAO, as well as adherence to CDC and WHO guidelines when considering biosecurity measures and vaccine development for economically significant pathogens.

In terms of classification criteria, modern molecular techniques utilizing next-generation sequencing (NGS) and max-likelihood phylogenetics have been instrumental in dissecting the evolutionary relationships among ARV strains [11]. In addition to the σC gene, complete genome sequencing of all 10 segments provides a holistic view of the virus’s genetic constellation. The identification of unique sequence motifs, insertions, deletions, and reassortment patterns along the genomic segments enriches our understanding of viral evolution and is pivotal to refining ARV taxonomy [6, 11]. These advances have led to a constellation-based classification scheme that groups ARV strains into distinct genotypes with epidemiological relevance, thereby enabling more precise tracking of viral dissemination across poultry farms and borders [5].

Overall, the taxonomy of avian reovirus is characterized by its segmented genomic structure, distinct antigenic proteins, and notable genetic heterogeneity, all of which mirror the virus’s extensive host adaptability and global distribution. With ongoing molecular surveillance and phylogenetic studies, the classification schema for ARV continues to evolve, integrating data on both genetic variation and phenotypic differences that influence virus pathogenesis and vaccine efficacy [8, 12]. This detailed understanding offers critical insights into the biological mechanisms underpinning ARV replication and immune evasion, and it serves as the foundation for developing next-generation vaccines and control strategies aimed at mitigating the economic burden of this pathogen as recommended by the FAO and WHO.

Molecular Pathogenesis of Avian Reovirus

Avian reovirus is a multifaceted pathogen whose molecular pathogenesis involves a complex interplay between viral proteins and various host cellular processes. Its pathogenesis is driven by specific viral components, most notably the nonstructural protein p17, as well as the structural proteins σA and σC, that coordinate to subvert host immune responses, manipulate signaling cascades, reprogram cell metabolism, arrest cell cycle progression, and promote viral dissemination.

Viral Protein–Mediated Modulation of Cellular Signaling

The p17 protein of avian reovirus acts as a master regulator in disrupting normal cellular signaling. p17 is known to shuttle continuously between the nucleus and cytoplasm, and its nucleocytoplasmic trafficking is orchestrated by host factors such as heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and lamin A/C. Studies have demonstrated that p17 contains a nuclear export signal that binds hnRNP A1, facilitating its efficient passage into the nucleus via a carrier-cargo complex involving transportin 1 [24]. This precise regulation of p17 localization is critical for the protein’s ability to interfere with host cell cycle regulators. By binding to key cell cycle factors, such as cyclin-dependent kinases (CDKs) and their cyclin partners, p17 suppresses not only CDK–cyclin complexes but also CDK-activating kinase activity, thereby promoting cell cycle arrest and creating an environment conducive to viral replication [22, 26]. This interference is further accentuated by p17’s capacity to enhance interactions between the tumor suppressor p53 and cyclin H, thereby indirectly reinforcing the negative regulation of cell cycle progression [22]. Additionally, p17 is involved in modulating the PI3K/Akt signaling pathway through its inhibition of mTOR complex assembly and CDK2/cyclin A2 activity, culminating in the downregulation of Akt phosphorylation, a modification necessary for cell survival and proliferation [17, 26].

The σA protein also plays a pivotal role by reprogramming host cellular metabolism and energy production. σA has been characterized as an activator of cellular energy metabolism through its ability to upregulate key glycolytic and tricarboxylic acid (TCA) cycle enzymes. Specifically, σA can elevate the levels of hypoxia-inducible factor 1α (HIF-1α), c-myc, and glut1, which collectively stimulate both glycolysis and glutaminolysis [15, 23]. By suppressing enzymes such as lactate dehydrogenase A (LDHA) and promoting the activity of enzymes like isocitrate dehydrogenase 3 subunit beta (IDH3B) and glutamate dehydrogenase (GDH), σA redirects cellular metabolism away from lactate fermentation toward pathways that yield larger quantities of ATP. This metabolic shift not only favors viral replication by providing ample energy but also creates a cellular microenvironment that facilitates virus assembly and release.

Evasion of the Host Innate Immune Response

Avian reovirus deploys a range of strategies to circumvent host immune defenses. One prominent mechanism involves the direct subversion of type I interferon responses. The σA protein has been shown to inhibit the production of interferon-β (IFN-β) by interacting with interferon regulatory factor 7 (IRF7), thereby blocking IRF7 dimerization and its nuclear translocation [18]. This targeted interference with interferon signaling allows the virus to escape early antiviral responses, facilitating unchecked viral replication. In parallel, p17-mediated induction of autophagy further contributes to immune evasion. By triggering autophagosome formation via activation of phosphatase and tensin homolog (PTEN) and AMP-activated protein kinase (AMPK), as well as engaging dsRNA-dependent protein kinase (PKR)/eIF2α signaling pathways, p17 creates a cellular milieu that not only favors the clearance of damaged cellular content but also assists in the release and spread of progeny viruses [27]. This autophagic process has been observed both in vitro and in avian tissue, where increased levels of LC3-II and accumulation of autophagosomes correlate with elevated viral loads during early infection [25, 27].

Regulation of Host Protein Stability and Trafficking

A key aspect of avian reovirus pathogenesis is the stabilization of its own proteins within host cells. Viral proteins such as σC, σA, and nonstructural protein σNS are safeguarded from degradation by hijacking host chaperone complexes. The Hsp90/Cdc37 complex and the chaperonin TRiC play critical roles in protecting these viral proteins from ubiquitin-proteasome-mediated degradation, thereby ensuring their proper folding, stability, and function within viral factories [16, 21]. This stabilization mechanism is essential for the high-efficiency assembly of virions and contributes to the overall replicative advantage of the virus.

Furthermore, the nucleocytoplasmic shuttling of p17 is intricately linked to its capacity to alter host cell trafficking. By binding to nuclear transport proteins and by utilizing an evolutionarily conserved nuclear export signal, p17 influences the distribution of host cellular proteins, including those involved in maintaining cell structure and function at the nuclear envelope [24]. Such perturbations in host protein localization disrupt normal cellular homeostasis and further facilitate virus replication.

Impact on Cell Cycle, Apoptosis, and Metabolic Reprogramming

The combined effects of p17-mediated cell cycle arrest and σA-induced metabolic reprogramming contribute to a cellular state that is both hostile to normal proliferation and highly beneficial to virus production. Arresting the cell cycle at the G2/M transition, predominantly through the inhibition of multiple CDK–cyclin complexes, allows avian reovirus to prevent cellular defenses normally activated during mitosis and simultaneously preserve cellular resources for viral propagation [19, 22, 26]. In addition, modulation of apoptosis is evident during ARV infection. MicroRNAs such as gga-miR-29a-3p have been shown to suppress virus-induced apoptosis by targeting caspase-3, highlighting the delicate balance between host cell death and viral replication [20]. This balance ensures that while some level of apoptosis aids in the release of viral particles, excessive cell death does not prematurely terminate the viral replication cycle.

The profound reprogramming of host cell metabolism is also critical. By enhancing the activity of key metabolic pathways through upregulation of HIF-1α and associated transcription factors, the virus effectively increases the intracellular pool of ATP and metabolic intermediates necessary for the synthesis of viral proteins and nucleic acids [15, 23]. Additionally, this metabolic shift, away from lactate production toward the TCA cycle and glutaminolysis, ensures a high-energy state conducive to efficient viral replication and maturation.

Integration of Host-Chaperone Interactions and Signal Transduction

The integration of host-chaperone interactions with signal transduction pathways underscores the sophisticated nature of avian reovirus molecular pathogenesis. By co-opting chaperone systems such as Hsp90/Cdc37 and TRiC, the virus not only protects its own proteins from degradation but also manipulates host cell signaling to maintain an environment favorable to replication [16, 21]. In parallel, the suppression of key survival pathways, most notably the PI3K/Akt pathway, by viral proteins such as p17 further skews the balance toward cellular autophagy and apoptosis, processes that ultimately enhance viral dissemination.

Given the significant economic impact of avian reovirus on poultry production, understanding these molecular mechanisms is essential for developing innovative control strategies. Regulatory agencies such as the CDC, WHO, and the WOAH emphasize the importance of vigilant molecular surveillance of economically significant pathogens. This molecular-level understanding of avian reovirus pathogenesis not only informs vaccine and antiviral design but also contributes to global efforts aimed at minimizing the economic losses in the poultry industry [WHO, FAO].

Epidemiological Trends and Field Investigations

Field investigations and systematic surveillance of avian reovirus (ARV) have exposed an intricate mosaic of viral genetic diversity and widespread distribution across diverse poultry systems. Over recent decades, outbreaks of viral arthritis/tenosynovitis, a hallmark of ARV infection, have been reported in multiple countries including China, Brazil, Israel, Japan, Iran, and the United States. Detailed molecular epidemiological studies have played a pivotal role in revealing the genetic evolution of ARV strains, assessing vaccine mismatches, and ultimately guiding field control strategies that align with guidelines from authoritative bodies such as the FAO, CDC, and WHO.

Investigations in China have captured a dynamic epidemiological trend wherein widespread sampling from outbreak regions revealed a high prevalence of ARV in commercial poultry flocks. For instance, studies involving thousands of samples collected across several provinces have demonstrated that ARV strains can be genetically grouped into multiple distinct branches based on the sigma C (σC) gene, a key component in virus attachment and immunity induction [31]. These investigations employed advanced RT-PCR techniques and virus isolation methods from joint tissues and tendons, providing not only molecular characterization but also quantitative assessment of viral load in clinically affected birds. Notably, the phylogenetic evaluations have unearthed low nucleotide sequence identity among some circulating isolates compared to vaccine strains, highlighting potential reasons for vaccine failure and recurrent disease outbreaks [4, 31].

In the field, studies carried out in regions such as Pennsylvania in the United States have underscored regional variations in ARV epidemiology. Investigators assessed over a thousand commercial flocks and established that distinct genotypic clusters exhibit strong spatial and temporal patterns [9]. These field investigations revealed that some states have higher rates of ARV detection in tissues like the intestine and tendons, correlating with clinical signs such as lameness and arthritis. The use of RT-PCR and viral culture in specialized cell lines confirmed that the emerging field variants were not only genetically distinct from vaccine strains, but also exhibited varying degrees of pathogenicity and transmission dynamics, a trend that echoes similar observations from other parts of the world [11, 28].

Brazilian field investigations have been instrumental in elucidating the diversity of ARV strains in different production systems. Extensive sampling from both broiler and breeder flocks has yielded multiple ARV genetic variants with evidence of coinfection with other pathogens such as fowl adenovirus [35]. Molecular characterization techniques, including partial σC gene sequencing, have allowed researchers to subdivide ARV isolates into several genotypic lineages. Notably, phylogenetic trees constructed from large sequence datasets have demonstrated that some ARV variants share as little as 40% similarity with commercial vaccine strains used in the region. This low identity is particularly concerning because it suggests that antigenic drift and reassortment are actively shaping the viral population, thereby diminishing vaccine efficacy and facilitating recurrent outbreaks in the backyard and commercial settings [35, 38].

In Egypt and Israel, field investigations have highlighted the challenges associated with vaccine mismatches as well as the economic burden imposed by these infections. Investigators have reported that despite routine vaccination programs in breeder flocks, outbreaks of ARV-associated tenosynovitis persist. Molecular analyses comparing vaccine strains with field isolates revealed distinct clustering, where many field isolates exhibited only 55–60% sequence homology to vaccine strains [33, 34]. In Israel particularly, multivalent autogenous vaccine developments have been prompted by the detection of co-circulating variants. Detailed molecular screenings using RT-PCR and sequencing methods have thus become indispensable components of ARV surveillance programs. These studies underscore a broader epidemiological pattern: the continual emergence of new genotypes driven by high mutation rates and selective pressures from widespread vaccination practices [13, 36].

Field investigations have also shed light on transmission dynamics, including both vertical and horizontal transmission routes. Research conducted in hatcheries has provided compelling evidence that ARV can be transmitted vertically from breeder flocks to progeny, with infected embryos subsequently serving as reservoirs for horizontal dissemination among chicks [30]. Field sampling protocols in hatcheries, which involve the collection of dead embryos and weak chicks followed by rigorous molecular testing, have revealed positivity rates that underscore the importance of vertical transmission in sustaining virus circulation. Such findings have critical implications for biosecurity measures and have been referenced by international organizations such as the WHO and CDC when outlining strategies to mitigate economic losses in poultry production.

Methodologically, the field investigations have evolved to incorporate state-of-the-art molecular techniques. For instance, novel assays combining reverse transcription-recombinase-aided amplification (RT-RAA) with CRISPR/Cas12a detection have significantly expedited the identification of ARV in field settings [29]. These assays provide sensitivity at very low copy numbers, enabling rapid on-site diagnosis that is essential for prompt intervention, prevention of spread, and minimizing economic disruption, a consideration that is echoed by guidelines from the FAO, which stress early diagnosis as a key step in controlling economically significant diseases.

Furthermore, epidemiological surveillance has not been limited solely to intensive commercial operations. Studies in backyard chicken populations in regions such as Bangladesh have revealed unexpectedly high seroprevalence rates, illustrating that ARV is endemic in low-biosecurity environments as well [37, 39]. In these settings, the detection of ARV-specific antibodies even in the absence of overt clinical signs indicates a subclinical spread, which poses a hidden threat to the overall health of the poultry sector. Such findings emphasize the need for enhanced surveillance in diverse production systems and stress the importance of integrated biosecurity practices that combine molecular testing, serological surveys, and environmental sampling.

The genetic reassortment events observed among different segments of the ARV genome add another layer of complexity to the epidemiological trends. Field investigations employing whole-genome sequencing have revealed mosaicism in viral strains, which in turn complicates the development of universally effective vaccines [11, 32]. The constant interplay between emerging field variants and vaccine strains necessitates continuous molecular epidemiological monitoring. As highlighted by numerous field investigations, an improved understanding of these genetic dynamics would allow for more targeted vaccine updates and better control strategies that are informed by authoritative organizations like the WOAH, CDC, and FAO.

Overall, the field investigations into ARV epidemiology have unraveled a multifaceted scenario where persistent viral circulation, extensive genetic diversity, and gaps in vaccine protection converge to challenge current control measures. The integration of advanced molecular diagnostics, continuous surveillance, and in-depth phylogenetic analyses is paramount not only to understanding the spread of ARV but also to formulating timely and effective intervention strategies in the poultry industry worldwide.

Advanced Diagnostic Methodologies for Avian Reovirus

The diagnostic landscape for avian reovirus (ARV) has evolved substantially over recent years, driven by the need to accurately detect diverse viral strains causing significant economic losses in poultry production. Given the virus’s genetic variability and spread across various geographical regions, modern diagnostic methodologies integrate multiple molecular, serological, and histopathological approaches to achieve rapid, sensitive, and specific detection. Advanced diagnostic tools now allow not only for the confirmation of ARV presence in suspect samples but also for epidemiological tracking and differentiation between vaccine and field strains, which are critical for disease control strategies endorsed by agencies such as the World Organisation for Animal Health (WOAH) and the U.S. Centers for Disease Control and Prevention (CDC).

Molecular and Nucleic Acid-Based Assays

Molecular diagnostics remain the cornerstone of ARV detection. Reverse transcription polymerase chain reaction (RT-PCR) has been widely adopted as a primary tool for identifying viral genetic material from tissue samples, particularly in cases presenting with arthritis or tenosynovitis lesions. In this approach, highly specific primers targeting conserved regions within genes such as σC ensure reliable amplification even in the presence of genetic variability [41, 45]. Quantitative real-time RT-PCR (qRT-PCR) assays further allow for viral load quantification, which can correlate with the severity of clinical lesions and inform epidemiological investigations [41].

Moreover, novel methods such as strand-specific qPCR have advanced our understanding of ARV replication kinetics, providing refined discrimination between replicative viral genomes and transcriptional byproducts [40]. In parallel, next-generation sequencing (NGS) approaches offer full genomic characterization, which not only aids in genotyping and evolutionary analyses but also informs the development of improved vaccines by highlighting mutation hotspots and reassortment events [11, 33].

The integration of isothermal nucleic acid amplification techniques has recently marked a turning point in field diagnostics. For example, the reverse transcription–recombinase-aided amplification (RT-RAA) method, when combined with CRISPR/Cas12a-based detection systems, has demonstrated unprecedented sensitivity with a detection limit as low as 1 copy/µL. This assay operates at a constant temperature and produces results within 40 minutes, making it particularly attractive for use in resource-limited settings and on-site outbreak investigations [29]. Such assays complement traditional qRT-PCR techniques and further reduce the dependency on sophisticated thermocycling equipment, aligning with the rapid response strategies recommended by international regulatory bodies like the FAO.

Serological and Protein-Based Detection Strategies

Serological assays continue to play a pivotal role in the surveillance of ARV infections in poultry flocks. Enzyme-linked immunosorbent assays (ELISAs) based on recombinant proteins, such as full-length σB, σC, and σNS or their specific fragments, have been meticulously developed to assess the immune status of flocks. These assays are designed to overcome limitations associated with traditional commercial ELISAs, which typically fail to differentiate between antibodies generated by vaccination and natural infection [42].

Careful selection and mapping of immunodominant epitopes, such as σB amino acids 128–179 and σC amino acids 121–165, has enabled enhanced diagnostic specificity. These protein fragment ELISAs have provided insights into the high antigenic diversity present among circulating field strains compared to vaccine strains, thereby aiding in vaccine efficacy assessments and guiding immunization programs [42]. Additionally, the development of ELISAs that utilize recombinant proteins has facilitated large-scale seroepidemiological surveys, which are essential to monitor virus prevalence and transmission dynamics in different production systems [37, 43].

Histopathology and In Situ Hybridization

In complex cases, especially where ARV-induced lesions are involved, a combination of histopathological examination with molecular techniques such as in situ hybridization (ISH) proves invaluable. Histopathology remains a gold standard for investigating tissue lesions associated with viral arthritis and tenosynovitis. Detailed microscopic analyses reveal characteristic inflammatory patterns, synovial proliferation, and lymphoid aggregation that, when coupled with ISH, allow for the precise localization of viral transcripts within affected tissues [41].

ISH techniques enable the detection of viral RNA directly within the cellular architecture, thus confirming the presence of live virus and its replication within specific cell populations such as synoviocytes or fibroblasts. This method can complement qRT-PCR data by providing spatial context, a diagnostic feature that is particularly critical for understanding tissue tropism and the pathogenesis of ARV infections. Moreover, the combination of ISH with histopathology establishes a direct correlation between viral replication, lesion severity, and overall host pathology, offering additional layers of diagnostic precision in cases where clinical symptoms may be ambiguous [41].

Emerging and Rapid Assays

Beyond traditional nucleic acid and serological methods, the field has seen a surge in the development of novel, rapid assays that aim to simplify and accelerate the diagnostic workflow. Recently, the feasibility of plaque assays has been revisited using optimized avian cell lines capable of supporting ARV growth, enabling the quantification of viral infectivity in a more standardized manner [3]. While traditional methods such as TCID50 provide a measure of viral replication, the plaque assay framework offers a visually quantifiable metric that bolsters both qualitative and quantitative diagnostic outputs.

Additionally, recent work on real-time recombinase polymerase amplification (RT-RPA) demonstrates the potential of isothermal amplification methods to further streamline ARV detection. These assays exploit the rapid nature of enzyme-mediated DNA synthesis without the thermal cycling required in PCR, potentially enabling point-of-care diagnostics that meet the rigorous demands of outbreak scenarios [44]. Such advancements are critical in regions where laboratory infrastructure is limited, and rapid, field-deployable diagnostic tools are essential for timely disease intervention, in line with strategies promoted by the CDC and WHO.

Moreover, diagnostic research has increasingly focused on integrating multiple detection platforms to create robust algorithms capable of high-throughput screening. Combining molecular, serological, and histological findings culminates in a comprehensive diagnostic picture that is vital for effective surveillance and management of ARV outbreaks. This integrative approach not only enhances diagnostic accuracy but also supports epidemiological investigations by linking molecular strain characteristics with clinical and pathological manifestations [11, 33, 41, 42].

As avian reovirus continues to challenge the poultry industry globally, advanced diagnostic methodologies form the backbone of effective disease management. Collaboration between research institutions, governmental bodies, and international organizations such as the CDC and WOAH, along with the continuous evolution of diagnostic assays, ensures that surveillance efforts remain current and effective in detecting and mitigating ARV outbreaks.

Pathogenicity and Clinical Manifestations in Poultry

Avian reovirus (ARV) is recognized as one of the most economically significant viral pathogens affecting the global poultry industry. Characterized by a multifaceted pathogenic profile, ARV manifests predominantly as viral arthritis/tenosynovitis in chickens while inciting additional clinical syndromes such as malabsorption, respiratory distress, and enteric disorders. Experimental studies using specific pathogen-free (SPF) chicken embryos and chicks have demonstrated that highly virulent ARV strains can induce high mortality and severe joint lesions, including swelling and inflammation particularly evident in the gastrocnemius and digital flexor tendons [41, 46]. These clinical manifestations extend beyond joint pathology and include systemic signs such as poor weight gain, leg splaying, and reduced hatchability which, in some cases, are the consequence of vertical transmission [30].

Clinical Signs and Tissue Tropism

Clinically, affected poultry display signs that range from overt lameness and joint swelling to more subtle intestinal disturbances. In naturally infected flocks, the disease is further characterized by arthritis, tenosynovitis, and occasionally, by a retarded growth syndrome that significantly compromises productivity [4, 46]. Lesions are often multifocal, with gross pathology revealing swollen hock joints and discoloration of infected tendons. Histopathological evaluation consistently uncovers diffuse inflammatory infiltrates – including heterophils, macrophages, lymphocytes, and plasma cells – within the synovial membranes and peritendinous tissues, along with fibrinous exudation and neovascularization [41, 49]. These pathologic features not only reflect the direct cytopathic effects of the virus on synovial fibroblasts and chondrocytes but also indicate a robust immunological response that may exacerbate tissue damage.

The propensity of the virus to replicate in both tendon and intestinal tissues suggests a dual tropism that complicates the clinical picture. Remarkably, transcriptomic analyses conducted in infected embryonic tissues indicate time- and dose-dependent viral replication patterns. For instance, high levels of viral RNA have been detected in the intestinal tract, a site that mounts a profound gene expression response implicating early immune activation, while joint tissues demonstrate sustained inflammation over a protracted period [47, 49]. The overlapping distribution of ARV within both enteric and articular tissues is consistent with observations that affected flocks often display signs of malabsorption concurrently with joint inflammation.

Molecular Determinants of Pathogenicity

At the molecular level, the virulence of ARV is closely tied to the properties and interactions of its viral proteins, among which the nonstructural protein p17 plays a pivotal role. p17 has been shown to trigger autophagy in host cells, an effect that not only facilitates virus replication but also contributes to cellular stress and apoptosis, thereby intensifying tissue damage [27, 48]. Its capacity to modulate multiple host signaling pathways, including activation of the p53 and PTEN pathways, leads to a blockade of cell cycle progression and compromises cellular repair mechanisms. These effects, in turn, ensure efficient viral replication and persistent cytopathic effects within the infected tissue, further driving joint degeneration and clinical arthritis [26, 48].

Another critical viral protein, σC, is responsible for receptor recognition and initiating the viral entry process. Genetic variability within the σC gene among different ARV isolates has been linked to differences in pathogenic characteristics, with some emergent strains showing notably reduced amino acid identity compared to classical vaccine strains such as S1133 [4, 28]. Such molecular diversity is thought to contribute to variable disease severity and the occasional failure of commercially available vaccines. In some cases, isolates with distinct σC profiles have been associated with more severe lesions in the liver, heart, and tendons, pointing to a genotype-dependent variation in tissue tropism and pathogenic potential [4, 49].

Further complexity in ARV pathogenesis arises from the virus’s ability to subvert host cellular processes. Investigations using de novo cultured cells and in ovo inoculation techniques have documented that ARV can manipulate cellular transcriptional networks, alter signaling cascades inherent to innate immunity, and co-opt molecular chaperones to stabilize viral proteins [16, 21]. Such modifications interfere with normal cell homeostasis, ultimately leading to heightened inflammatory responses and tissue injury that are hallmarks of the disease process.

Epidemiological Context and Field Observations

Epidemiologically, outbreaks of ARV-related arthritis have been reported across multiple geographic regions including Asia, the Americas, and parts of Europe, reinforcing its status as an economically critical pathogen, a concern also echoed by international bodies such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) [7, 12]. In field studies, the detection of ARV-positive cases in chickens under 70 days of age, particularly in flocks experiencing co-infections with other arthrogenic viruses, underscores the heightened vulnerability of young birds. Clinical manifestations in these rapidly growing birds are often severe, with leg abnormalities and reduced hatchability observed among vertically transmitted cases [1, 30]. Notably, in some instances, early signs such as transient watery droppings or mild lameness precede the onset of classical joint lesions, suggesting that early detection remains pivotal in mitigating disease progression.

The heterogeneity of clinical outcomes, ranging from subclinical infections to overwhelming systemic disease, is largely reflective of the interplay between viral genotype, host immune competence, and environmental factors. Critical assessments in experimental settings have demonstrated that the severity of lesions in joints correlates with high viral RNA loads, thereby highlighting the importance of viral replication dynamics in determining clinical severity [41, 49]. Such insights reinforce the strategic need for robust surveillance and periodic updating of vaccine formulations to match circulating field strains. As recommended by authoritative agencies including the CDC and FAO for other economically critical poultry pathogens, effective biosecurity measures and continuous molecular epidemiological monitoring are imperative to control ARV outbreaks [7, 12].

Overall, the pathogenicity and clinical manifestations induced by ARV in poultry result from a complex convergence of direct viral cytopathicity, virus-induced modulation of host immune and metabolic pathways, and variability among viral isolates. This multifactorial nature of ARV pathogenesis necessitates comprehensive approaches to diagnosis, treatment, and prevention within the integrated framework of poultry health management.

Host-Virus Interactions and the Immune Response in Avian Reovirus Infection

Avian reovirus (ARV) has evolved a complex array of mechanisms to interact with host cells and modulate the immune response. At the very outset, ARV exploits specific cell-surface receptors to facilitate its entry. Studies demonstrate that ARV attachment is mediated by interactions with cellular proteins such as annexin A2 and adhesion G protein‐coupled receptor Latrophilin‐2. Engagement of these proteins activates downstream signaling cascades, including Src and p38 MAPK pathways, which in turn promote caveolae-dependent endocytosis and dynamin-mediated uptake of the virus into host cells [10]. Once the virus is internalized, the interplay between viral components and host molecular machinery begins a finely tuned battle between immune evasion and host defense.

Early Recognition and Interferon Signaling

Upon entry, cellular pattern recognition receptors (PRRs) rapidly detect the presence of viral RNA. This activation results in the upregulation of type I interferons (IFN-α and IFN-β) and other cytokines that serve as the initial alarm signal for the innate immune response. Notably, ARV deploys proteins such as σA to counteract this antiviral state, σA has been shown to inhibit IFN-β production by directly interacting with interferon regulatory factor 7 (IRF7) and preventing its dimerization and nuclear translocation [18]. This targeted suppression of interferon production undermines the host’s frontline defense, thereby facilitating enhanced viral replication.

The downstream activation of interferon-stimulated genes (ISGs) is pivotal for establishing an antiviral state. Transcriptomic and translatomic analyses in the spleen of specific-pathogen-free (SPF) chickens have revealed marked changes in the expression of ISGs, such as IFITM3, IFIT5, IFI6, and VIPERIN, in direct correlation with viral load [53, 54]. These ISGs work by blocking various stages of virus replication and assembly. However, ARV has evolved strategies to circumvent these defenses, resulting in a dynamic interplay where the balance of viral replication versus host immunity determines the course of infection.

Modulation of Autophagy and Apoptosis

A striking feature of ARV infection is the ability of the virus to manipulate autophagy, a cellular degradation process that can serve both protective and proviral functions. ARV proteins, particularly the nonstructural protein p17, trigger autophagy by modulating distinct signaling pathways. p17 can induce autophagy-mediated cargo trafficking of progeny viruses to extracellular vesicles, thereby enhancing virus release [50]. Moreover, p17 collaborates with viral regulatory proteins to suppress the mammalian target of rapamycin complex 1 (mTORC1) and disrupt critical cell cycle regulatory CDK–cyclin complexes via upregulation of p53, culminating in cell cycle arrest [22, 51]. This suppression reallocates cellular resources, effectively favoring viral protein synthesis over cellular proliferation.

Autophagic responses not only facilitate viral egress but are intricately linked to apoptosis. ARV-induced autophagy can mitigate or delay apoptotic cell death, providing a window for robust viral replication. Concurrently, host microRNAs (miRNAs) fine-tune these processes; for instance, gga-miR-30c-5p targets autophagy-related gene 5 (ATG5), reducing autophagic flux and thereby altering the balance between cell survival and death [52]. Similarly, gga-miR-29a-3p suppresses virus-induced apoptosis by targeting key apoptotic mediators such as Caspase-3 [20]. This dual modulation of autophagy and apoptosis exemplifies the virus’s ability to harness host cellular machinery to prolong the replication cycle while preventing premature cell death.

Interactions with Cellular Chaperones and Protein Quality Control

ARV also manipulates host protein quality control systems to secure an environment conducive to viral replication. The virus harnesses cellular chaperones such as Hsp90/Cdc37 and the TRiC complex to stabilize its own proteins. For instance, the p17 protein is identified as an Hsp90 client; its stabilization through the Hsp90/Cdc37 complex prevents ubiquitin-proteasome degradation, thereby facilitating efficient virus production [16]. Likewise, TRiC chaperonins have been shown to safeguard viral outer-capsid protein σC and inner core protein σA from degradation [21]. These interactions ensure the accumulation and correct folding of viral proteins, which are essential for the formation of productive viral factories within host cells. Such hijacking of host chaperone systems not only disrupts normal cellular homeostasis but also impairs the host’s ability to mount an effective antiviral response.

Alterations in Host Signaling and Cell Cycle Regulation

The ability of ARV proteins to modulate host cell cycle regulators further highlights the sophisticated nature of host-virus interactions. ARV p17, for example, interacts directly with cell cycle mediators, including CDK2, cyclin A2, and even the checkpoint protein Bub3, thereby arresting the cell cycle at the G2/M phase [19, 22, 51]. This arrest not only curtails cell division but redirects cellular energy and biosynthetic resources towards viral replication. Additionally, ARV p17 interferes with nucleocytoplasmic shuttling by forming complexes with hnRNP A1 and lamin A/C, mechanisms that are crucial for controlling the localization and activity of both viral and host proteins [24]. These alterations disrupt normal immune signaling pathways and can diminish the host’s capacity for antigen processing and presentation, thereby impacting adaptive immunity.

MicroRNA-Mediated Regulation of the Immune Response

MicroRNAs are emerging as critical regulators of the host immune response during ARV infection. Through post-transcriptional modulation, these small RNAs influence the expression of numerous immune-related genes. For example, gga-miR-200a-3p has been shown to limit apoptosis by targeting the growth factor receptor-bound protein 2 (GRB2), which results in reduced ARV replication [52]. Conversely, downregulation of gga-miR-29a-3p facilitates higher Caspase-3 activity and increased apoptosis, a state that paradoxically may either curb or promote viral spread depending on the timing and extent of the apoptotic response [20]. Thus, the differential expression of miRNAs in ARV-infected cells underscores the nuanced interplay between host defense mechanisms and viral strategies aimed at subverting these responses.

Epidemiological Context and the Need for Enhanced Immune Surveillance

The adaptive strategies of ARV extend into its epidemiological impact. Widespread circulation of diverse ARV strains is documented across

Emerging Strains and Genomic Evolution of Avian Reovirus

Recent studies have revealed that the continual emergence and diversification of avian reovirus (ARV) strains is driven by complex evolutionary processes that impact both genomic architecture and pathogenic potential. Deep genomic analyses have illuminated that ARV, a double-stranded RNA virus notorious for its economic impact on poultry, displays a high degree of genetic variability that is most prominently evidenced in the σC protein–coding region. The σC protein, being the primary outer-capsid antigen and receptor-binding molecule, is subject to strong selective pressures from host immune responses and vaccination regimes. This intense immunological pressure has catalyzed the evolution of novel genotypes that often differ markedly from the classical vaccine strains [4, 8, 12].

Diversity of Genotypic Clusters and Reassortment Events

Phylogenetic studies have classified ARV isolates into several distinct genotypic clusters, with some reports identifying up to six major clusters based on the σC gene sequences [8, 28, 55]. This genotypic segregation not only reflects geographic and host-specific adaptations but also marks the historical footprints of viral evolution. For instance, studies conducted in Pennsylvania and California have demonstrated that field isolates can be clearly distinguished from vaccine strains, and that multiple clusters coexist with varying degrees of antigenic similarity [11, 28, 38]. The genomic diversification is further compounded by segment reassortment events. ARV possesses a segmented genome, which facilitates the exchange of entire gene segments during coinfection, a process that produces mosaic genomes with novel gene constellations [2, 28]. Such reassortment, particularly involving the genes encoding outer capsid proteins like σC, λC, and μB, is a critical driver of antigenic drift, and has been implicated in differences in virulence and transmissibility among emerging strains [2, 4, 28].

Molecular Evolution and Selective Pressure

The molecular evolution of ARV is underscored by high nucleotide substitution rates in key genomic segments such as the M2 and σC-encoding regions. Studies using temporal phylogenetics have tracked the evolutionary trajectory of these segments, revealing that selective pressure favors mutations that alter antigenic determinants, thus allowing the virus to persist in vaccinated populations [2, 4, 12]. The σC protein, in particular, shows low sequence homologies with classical vaccine strains in many regions, often less than 80%, and in some cases as low as 38–55% [4, 33]. These substitutions are not random; rather, specific amino acid changes in regions predicted to be involved in receptor binding and immune recognition have been documented, suggesting a targeted evolution to evade host humoral immunity [6, 46]. The pressure on these epitopes is further intensified by the widespread use of immunogens that stimulate the host’s neutralizing antibody repertoire, thereby selecting for variants that can escape vaccine-induced immunity, a scenario that has been reported in several geographic regions including Egypt and China [4, 6, 33, 45].

Host Range Expansion and Cross-Species Transmission

Genomic evolution in ARV is also reflected in its ability to infect a broad array of avian hosts beyond commercial chickens. Documented cases have shown isolation of ARV from turkeys, ducks, black swans, and even wild birds, pointing to a complex epidemiological network of interspecies transmission [56, 57]. Whole-genome sequencing and segment-based analysis have provided evidence that chickens are the ancestral hosts, with spillover events occurring in other species over the mid-20th century [2]. This interspecies host switching is not only an indicator of the evolutionary plasticity of the virus but also poses challenges for virus surveillance and control, as it can contribute to the persistence and spread of novel genotypes across regions and between wild and domestic populations [2, 8]. Agencies such as the CDC, WHO, and the World Organisation for Animal Health (WOAH) consistently underscore the importance of enhanced molecular surveillance, particularly for economically critical pathogens whose evolution can have dire impacts on the poultry industry.

Impact of Vaccination and Epidemiological Shifts

Vaccination strategies historically designed using classical strains such as S1133 have increasingly found themselves outpaced by emerging variants. It is now well established that strains circulating in the field often exhibit significant antigenic divergence from these vaccine strains, which in turn leads to breakthrough infections and persistent viral circulation [4, 11, 38]. For example, studies in the United States and Israel have reported that variants isolated from recent outbreaks belong to genotypic clusters distinct from the strains used in current commercial vaccines. This divergence has prompted the development of new genotyping schemes and constellation-based classification methods that provide better resolution of the evolutionary relationships among circulating strains [5, 8]. The evolving epidemiology of ARV, with shifting cluster dominance, as well as the detection of new sub-lineages, highlights the need for continuous surveillance and genomic characterization to guide vaccine redesign and optimize control strategies [8, 36].

Mechanisms Driving Evolution and Genomic Plasticity

At the molecular level, typical evolutionary adaptations observed in ARV include point mutations, insertions, and deletions in the σC region that can alter both its structural conformation and antigenic properties [6]. These genetic modifications frequently occur in functionally critical domains, such as the heptad repeat region of the σC coding gene, where even subtle changes in hydrophobicity and motif length may preserve protein function while facilitating immune escape [6]. Moreover, the segmented nature of the ARV genome predisposes it to genetic reassortment during co-circulation, thereby rapidly generating diverse viral progeny with novel antigenic profiles [2, 28]. In this context, complete genome analyses have been instrumental in revealing that while certain segments, particularly those within the inner core, remain more conserved, the outer capsid proteins are subject to rapid evolution as a consequence of adaptive immune pressure [11, 38]. Such a dual evolutionary process underscores the inherent genomic plasticity of ARV, contributing significantly to its persistence and epidemiological success in a range of poultry populations worldwide [12, 38].

Integrating Genomic Data for Future Surveillance

Advanced genomic approaches, including high-throughput sequencing and phylodynamic analyses, are now central to unraveling the intricate evolutionary pathways of ARV. These studies integrate vast datasets of σC sequences from diverse geographic regions and different host species, allowing researchers to trace the origin, migration, and emergence of novel strains over time [8, 11, 38]. With such integrative techniques, epidemiologists and virologists can better predict the spread of emerging strains and guide the implementation of targeted vaccination programs, as recommended by international regulatory bodies such as the CDC, WHO, and WOAH. This molecular and evolutionary perspective is critical for developing robust strategies that address both the economic and public health challenges associated with ARV.

References

[1] Faria VBd, Silva CC, Damaso PdP, Savoldi IR, Sommerfeld S, Fonseca B. Epidemiological insights into fowl adenovirus, astrovirus, and avian reovirus in Brazilian poultry flocks: A cross-sectional study. Poultry Science. 2025. DOI: https://doi.org/10.1016/j.psj.2025.104964

[2] Hsueh C, Zeller MA, Hashish A, Fasina O, Piñeyro P, Li G, et al.. Investigation of Avian Reovirus Evolution and Cross-Species Transmission in Turkey Hosts by Segment-Based Temporal Analysis. Viruses. 2025. DOI: https://doi.org/10.3390/v17070926

[3] Harrell TL, Álvarez-Narváez S, Conrad SJ. Determination of a Suitable Avian Cell Line for the Quantification of Avian Reovirus via Plaque Assays.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-24-00100

[4] Niu S, Wu Z, Pan S, Ma T, Zhang Y, Xu B, et al.. Genetic and Pathogenic Characteristics of Variant Avian Reovirus Strains Isolated from Diseased Chickens in China. Microorganisms. 2025. DOI: https://doi.org/10.3390/microorganisms13112450

[5] Hsueh C, Zeller M, Hashish A, Fasina O, Piñeyro P, Aminu O, et al.. Constellation-based classification of avian reovirus in turkeys reveals shared virus origins among different meat-type farms. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1648247

[6] Sallam H, Saleh M, Haggag SY, Algaous MI. Molecular Characterization of Variant Egyptian Avian Reovirus Isolates with Nucleotide Insertions and Deletions at the σC Coding Gene.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-25-00004

[7] Nour I, Mohanty SK. Avian Reovirus: From Molecular Biology to Pathogenesis and Control. Viruses. 2024. DOI: https://doi.org/10.3390/v16121966

[8] Franzo G, Tucciarone C, Faustini G, Poletto F, Baston R, Cecchinato M, et al.. Reconstruction of Avian Reovirus History and Dispersal Patterns: A Phylodynamic Study. Viruses. 2024. DOI: https://doi.org/10.3390/v16050796

[9] Shabbir M, Yu H, Lighty ME, Dunn PA, Wallner-Pendleton EA, Lu H. Diagnostic investigation of avian reovirus field variants circulating in broiler chickens in Pennsylvania of United States between 2017 and 2022. Avian Pathology. 2024. DOI: https://doi.org/10.1080/03079457.2024.2342889

[10] Huang W, Wu Y, Liao T, Nielsen B, Liu H. Cell Entry of Avian Reovirus Modulated by Cell-Surface Annexin A2 and Adhesion G Protein-Coupled Receptor Latrophilin-2 Triggers Src and p38 MAPK Signaling Enhancing Caveolin-1- and Dynamin 2-Dependent Endocytosis. Microbiology spectrum. 2023. DOI: https://doi.org/10.1128/spectrum.00009-23

[11] Nour I, Álvarez-Narváez S, Harrell TL, Conrad SJ, Mohanty SK. Whole Genomic Constellation of Avian Reovirus Strains Isolated from Broilers with Arthritis in North Carolina, USA. Viruses. 2023. DOI: https://doi.org/10.3390/v15112191

[12] Egana-Labrin S, Broadbent A. Avian reovirus: a furious and fast evolving pathogen.. Journal of Medical Microbiology. 2023. DOI: https://doi.org/10.1099/jmm.0.001761

[13] Farnoushi Y, Heller DE, Lublin A. Genetic characterization of newly emerging avian reovirus variants in chickens with viral arthritis/tenosynovitis in Israel.. Virology. 2023. DOI: https://doi.org/10.1016/j.virol.2023.109908

[14] Wang Y, Zhang Y, Zhang C, Hu M, Yan Q, Zhao H, et al.. Cholesterol-Rich Lipid Rafts in the Cellular Membrane Play an Essential Role in Avian Reovirus Replication. Frontiers in Microbiology. 2020. DOI: https://doi.org/10.3389/fmicb.2020.597794

[15] Hsu C, Huang J, Huang W, Chen I, Chen M, Liao T, et al.. Oncolytic Avian Reovirus σA-Modulated Upregulation of the HIF-1α/C-myc/glut1 Pathway to Produce More Energy in Different Cancer Cell Lines Benefiting Virus Replication. Viruses. 2023. DOI: https://doi.org/10.3390/v15020523

[16] Huang W, Li J, Wu Y, Liao T, Nielsen B, Liu H. p17-Modulated Hsp90/Cdc37 Complex Governs Oncolytic Avian Reovirus Replication by Chaperoning p17, Which Promotes Viral Protein Synthesis and Accumulation of Viral Proteins σC and σA in Viral Factories. Journal of Virology. 2022. DOI: https://doi.org/10.1128/jvi.00074-22

[17] Li J, Huang W, Liao T, Nielsen B, Liu H. Oncolytic Avian Reovirus p17-Modulated Inhibition of mTORC1 by Enhancement of Endogenous mTORC1 Inhibitors Binding to mTORC1 To Disrupt Its Assembly and Accumulation on Lysosomes. Journal of Virology. 2022. DOI: https://doi.org/10.1128/jvi.00836-22

[18] Gao L, Liu R, Luo D, Li K, Qi X, Liu C, et al.. Avian Reovirus σA Protein Inhibits Type I Interferon Production by Abrogating Interferon Regulatory Factor 7 Activation. Journal of Virology. 2022. DOI: https://doi.org/10.1128/jvi.01785-22

[19] Tang J, Fu M, Chen X, Zhao Y, Gao L, Cao H, et al.. Arrest of Cell Cycle by Avian Reovirus p17 through Its Interaction with Bub3. Viruses. 2022. DOI: https://doi.org/10.3390/v14112385

[20] Zhou L, Li J, Haiyilati A, Li X, Gao L, Cao H, et al.. Gga-miR-29a-3p suppresses avian reovirus-induced apoptosis and viral replication via targeting Caspase-3.. Veterinary Microbiology. 2021. DOI: https://doi.org/10.1016/j.vetmic.2021.109294

[21] Huang W, Li J, Liao T, Yeh C, Wang C, Wen H, et al.. Molecular chaperone TRiC governs avian reovirus replication by protecting outer-capsid protein σC and inner core protein σA and non-structural protein σNS from ubiquitin- proteasome degradation.. Veterinary Microbiology. 2021. DOI: https://doi.org/10.1016/j.vetmic.2021.109277

[22] Chiu H, Huang W, Liao T, Chi P, Nielsen B, Liu J, et al.. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK–cyclin complexes and enhancement of p53 and cyclin H interaction. Journal of Biological Chemistry. 2018. DOI: https://doi.org/10.1074/jbc.RA118.002341

[23] Chi P, Huang W, Chiu H, Li J, Nielsen B, Liu H. Avian reovirus σA‐modulated suppression of lactate dehydrogenase and upregulation of glutaminolysis and the mTOC1/eIF4E/HIF‐1α pathway to enhance glycolysis and the TCA cycle for virus replication. Cellular Microbiology. 2018. DOI: https://doi.org/10.1111/cmi.12946

[24] Chiu H, Huang W, Wang Y, Li J, Liao T, Nielsen B, et al.. Heterogeneous Nuclear Ribonucleoprotein A1 and Lamin A/C Modulate Nucleocytoplasmic Shuttling of Avian Reovirus p17. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.00851-19

[25] Niu X, Zhang C, Wang Y, Guo M, Ruan B, Wang X, et al.. Autophagy induced by avian reovirus enhances viral replication in chickens at the early stage of infection. BMC Veterinary Research. 2019. DOI: https://doi.org/10.1186/s12917-019-1926-5

[26] Huang W, Chi P, Chiu H, Hsu J, Nielsen B, Liao T, et al.. Avian reovirus p17 and σA act cooperatively to downregulate Akt by suppressing mTORC2 and CDK2/cyclin A2 and upregulating proteasome PSMB6. Scientific Reports. 2017. DOI: https://doi.org/10.1038/s41598-017-05510-x

[27] Chi P, Huang WR, Lai I, Cheng C, Liu H. Correction: The p17 nonstructural protein of avian reovirus triggers autophagy enhancing virus replication via activation of phosphatase and tensin deleted on chromosome 10 (PTEN) and AMP-activated protein kinase (AMPK), as well as dsRNA-dependent protein kinase (PKR)/eIF2 α signaling pathways.. Journal of Biological Chemistry. 2019. DOI: https://doi.org/10.1074/jbc.AAC119.010041

[28] Kovács E, Varga-Kugler R, Homonnay Z, Tatár-Kis T, Mató T, Marton S, et al.. Pathogenicity disparities between two avian reovirus strains of the same genetic cluster. Avian Pathology. 2025. DOI: https://doi.org/10.1080/03079457.2025.2551119

[29] Zheng Q, Lu Z, Chen H, Li M, Zhang H, Cheng Z, et al.. Establishment of a Rapid and Efficient Method for the Detection of Avian Reovirus Based on RT-RAA-CRISPR/Cas12a Technology. Animals. 2025. DOI: https://doi.org/10.3390/ani15202994

[30] Chen L, Yin L, Li L, Wu z, Yang J, Yang S, et al.. Evidence for vertical transmission of avian reovirus in chickens.. Veterinary Microbiology. 2025. DOI: https://doi.org/10.1016/j.vetmic.2025.110710

[31] Liu D, Zou Z, Song S, Liu H, Gong X, Li B, et al.. Epidemiological Analysis of Avian Reovirus in China and Research on the Immune Protection of Different Genotype Strains from 2019 to 2020. Vaccines. 2023. DOI: https://doi.org/10.3390/vaccines11020485

[32] Liu R, Luo D, Gao J, Li K, Liu C, Qi X, et al.. A Novel Variant of Avian Reovirus Is Pathogenic to Vaccinated Chickens. Viruses. 2023. DOI: https://doi.org/10.3390/v15091800

[33] Zanaty A, Mosaad Z, Elfeil WMK, Badr M, Palya V, Shahein M, et al.. Isolation and Genotypic Characterization of New Emerging Avian Reovirus Genetic Variants in Egypt. Poultry. 2023. DOI: https://doi.org/10.3390/poultry2020015

[34] Mosad SM, Elmahallawy E, Alghamdi A, El-khayat F, El-khadragy MF, Ali L, et al.. Molecular and pathological investigation of avian reovirus (ARV) in Egypt with the assessment of the genetic variability of field strains compared to vaccine strains. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1156251

[35] Torre DIDl, Astolfi-Ferreira C, Chacón RD, Puga B, Ferreira AJP. Emerging new avian reovirus variants from cases of enteric disorders and arthritis/tenosynovitis in Brazilian poultry flocks. British Poultry Science. 2021. DOI: https://doi.org/10.1080/00071668.2020.1864808

[36] Goldenberg D. Avian Reovirus in Israel, Variants and Vaccines, A Review. Avian diseases. 2022. DOI: https://doi.org/10.1637/aviandiseases-D-22-99996

[37] Pinto SC, Aleixo J, Camela K, Chilundo AG, Bila C. Seroprevalence of infectious bronchitis virus and avian reovirus in free backyard chickens. Onderstepoort Journal of Veterinary Research. 2022. DOI: https://doi.org/10.4102/ojvr.v89i1.2042

[38] Carli SD, Wolf J, Gräf T, Lehmann F, Fonseca A, Canal C, et al.. Genotypic characterization and molecular evolution of avian reovirus in poultry flocks from Brazil. Avian Pathology. 2020. DOI: https://doi.org/10.1080/03079457.2020.1804528

[39] Islam M, Sabuj AAM, Haque ZF, Pondit A, Hossain M, Saha S. Seroprevalence and risk factors of avian reovirus in backyard chickens in different areas of Mymensingh district in Bangladesh. Journal of Advanced Veterinary and Animal Research. 2020. DOI: https://doi.org/10.5455/javar.2020.g452

[40] Harrell TL, Álvarez-Narváez S, Read Q, Conrad SJ. Novel strand-specific qPCR assay elucidates differences in viral replication kinetics between different strains of avian reovirus. Microbiology spectrum. 2025. DOI: https://doi.org/10.1128/spectrum.03140-24

[41] Hsueh C, Piñeyro P, Fasina O, Arunsiripate T, El-Gazzar MM, Sato Y. Viral tenosynovitis in poultry: Integrating histopathology, in situ hybridization, and quantitative reverse transcriptase-PCR for avian reovirus diagnostic workflow. Veterinary Pathology-Supplement. 2025. DOI: https://doi.org/10.1177/03009858251361516

[42] Matos TRAd, Palka A, Souza Cd, Fragoso S, Pavoni D. Detection of avian reovirus (ARV) by ELISA based on recombinant σB, σC and σNS full-length proteins and protein fragments.. Journal of Medical Microbiology. 2024. DOI: https://doi.org/10.1099/jmm.0.001836

[43] Elkadmiri AA, Zhari A, Aitlaydi N, Bouslikhane M, Fagrach A, Mouahid M, et al.. First Seroprevalence Survey of Avian Reovirus in Broiler Breeders Chicken Flocks in Morocco. Viruses. 2023. DOI: https://doi.org/10.3390/v15061318

[44] Ma L, Shi H, Zhang M, Song Y, Zhang K, Cong F. Establishment of a Real-Time Recombinase Polymerase Amplification Assay for the Detection of Avian Reovirus. Frontiers in Veterinary Science. 2020. DOI: https://doi.org/10.3389/fvets.2020.551350

[45] Mirbagheri SA, Hosseini H, Ghalyanchilangeroudi A. Molecular characterization of avian reovirus causing tenosynovitis outbreaks in broiler flocks, Iran. Avian Pathology. 2020. DOI: https://doi.org/10.1080/03079457.2019.1654086

[46] Ma X, Li W, Liu Z, Zuo Z, Dang X, Gao H, et al.. Isolation, Identification, and Pathogenicity of an Avian Reovirus Epidemic Strain in Xinjiang, China. Viruses. 2025. DOI: https://doi.org/10.3390/v17040499

[47] Khalid Z, Fathima S, Hauck R. Tissue-Specific Transcriptomic Responses to Avian Reovirus Inoculation in Ovo. Viruses. 2025. DOI: https://doi.org/10.3390/v17050646

[48] Hsu C, Li J, Huang W, Liao T, Wen H, Wang C, et al.. The oncolytic avian reovirus p17 protein suppresses invadopodia formation via disruption of TKs5 complexes and oncogenic signaling pathways. Frontiers in Cellular and Infection Microbiology. 2025. DOI: https://doi.org/10.3389/fcimb.2025.1603124

[49] McCullough K, Linnemann E, Gauthiersloan V, Sellers HS. Pathogenesis of an Avian Reovirus Isolate Displaying Enteric and Arthritic Tropisms.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-25-00007

[50] Hsu C, Huang W, Chiang I, Li J, Munir M, Liu H. Avian reovirus induces autophagy-mediated cargo of progeny viruses to extracellular vesicles and enhancement of virus release.. Veterinary Microbiology. 2025. DOI: https://doi.org/10.1016/j.vetmic.2025.110627

[51] Hsu C, Li J, Yang E, Liao T, Wen H, Tsai P, et al.. The Oncolytic Avian Reovirus p17 Protein Inhibits Invadopodia Formation in Murine Melanoma Cancer Cells by Suppressing the FAK/Src Pathway and the Formation of theTKs5/NCK1 Complex. Viruses. 2024. DOI: https://doi.org/10.3390/v16071153

[52] Zhao Y, Zhou L, Zheng H, Gao L, Cao H, Li X, et al.. Gga-miR-200a-3p suppresses avian reovirus-induced apoptosis and viral replication via targeting GRB2.. Veterinary Microbiology. 2024. DOI: https://doi.org/10.1016/j.vetmic.2024.110149

[53] Wang S, Huang T, Xie Z, Wan L, Ren H, Wu T, et al.. Transcriptomic and Translatomic Analyses Reveal Insights into the Signaling Pathways of the Innate Immune Response in the Spleens of SPF Chickens Infected with Avian Reovirus. Viruses. 2023. DOI: https://doi.org/10.3390/v15122346

[54] Wang S, Wan L, Ren H, Xie Z, Xie L, Huang J, et al.. Screening of interferon-stimulated genes against avian reovirus infection and mechanistic exploration of the antiviral activity of IFIT5. Frontiers in Microbiology. 2022. DOI: https://doi.org/10.3389/fmicb.2022.998505

[55] Zhang C, Zhang Q, Hu X, Wei L, Zhang X, Wu Y. IFI16 plays a critical role in avian reovirus induced cellular immunosuppression and suppresses virus replication.. Poultry Science. 2024. DOI: https://doi.org/10.1016/j.psj.2024.103506

[56] Zhu D, Sun R, Wang M, Jia R, Chen S, Liu M, et al.. First isolation and genomic characterization of avian reovirus from black swans (Cygnus atratus) in China. Poultry Science. 2023. DOI: https://doi.org/10.1016/j.psj.2023.102947

[57] Kim S, Choi Y, Park J, Wei B, Shang K, Zhang J, et al.. Isolation and Genomic Characterization of Avian Reovirus From Wild Birds in South Korea. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.794934